Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 4, 1999, Pages 526-532

  Looareesuwan, Sornchai ^a   Wilairatana, Poirat ^a   Chalermarut, Kobsiri ^a   Rattanapong, Yupin ^a   Canfield, Craig J ^b   Hutchinson, David B A ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Pharmaceutical Systems Inc   (United States)

^c Betsoms Farmhouse   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; BILIRUBIN; CREATININE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MEFLOQUINE; PROGUANIL; UREA;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHILIA; FEMALE; FEVER; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PARASITEMIA; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; SORE THROAT; THAILAND; VERTIGO; VOMITING;

EID: 0032927288     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.526     Document Type: Article

References (40)

1. Bunnag D, Harinasuta T, 1987. The current status of drug resistance in malaria. Int J Parasitol 17: 169-180.
2. Looareesuwan S, Harinasuta T, Chongsuphajaisiddhi T, 1992. Drug resistant malaria, with special reference to Thailand. Southeast Asian J Trop Med Public Health 23: 621-634.
3. Looareesuwan S, Wilairatana P, Vanijanonta S, Kyle D, Webster K, 1992. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand (letter). Lancet 339: 369.
4. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C,Webster HK, Edstein M, Phaipun L, Thew KL, White NJ, 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337: 1140-1143.
5. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ, 1993. Halofantrine versus mefloquine in treatment of multi-drug-resistant falciparum malaria. Lancet 341: 1044-1049.
6. Looareesuwan S, Viravan C, Vanijanonta S, Wilairantana P, Suntharasamai P, Charoenlarp P, Arnold K, Kyle D, Canfield C, Webster K, 1992. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339: 821-824.
7. Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, Kern W, Pohle HD, 1991. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 45: 86-91.
8. Bem JL, Kerr L, Stuerchler D, 1992. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg 95: 167-179.
9. Nosten F, ter Kuile FO, Luxemburger C,Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ, 1993. Cardiac effects of antimalarial treatment with halofantrine. Lancet 341: 1054-1056.
10. Monlun E, Le Metayer P, Szwandt S, Neau D, Longy-Boursier M, Horton J, Le Bras M, 1995. Cardiac complications of halofantrine: a prospective study of 20 patients. Trans R Soc Trop Med Hyg 89: 430-433.
11. Karlsson KK, Hellgren U, Alvan G, Rombo L, 1990. Audiometry as a possible indicator of quinine plasma concentration during treatment of malaria. Trans R Soc Trop Med Hyg 84: 765-767.
12. Danielson DA, Douglas SW III, Herzog P, Jick H, Porter JB, 1984. Drug-induced blood disorders. JAMA 252: 3257-3260.
13. Anonymous, 1993. Reynolds JEF, ed. Martindale, the Extra Pharmacopoeia. 13th edition. London: The Pharmaceutical Press, 212-216.
14. Hernborg A, 1985. Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique. Lancet 2: 1072-1073.
15. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Camphell CC, 1986. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar®) for malaria prophylaxis. Ant J Trop Med Hyg 35: 451-458.
16. Zitelli BJ, Alexander J, Taylor S, Miller KD, Howrie DL, Kuritsky JN, Perez TH, Van Thiel DH, 1987. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar®). Ann Intern Med 106: 393-395.
17. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG, 1996. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511-1514.
18. Bustos DG, Canfield CJ, Canete-Miguel E, Hutchinson DBA, 1999. Atovaquone/proguanil compared with chloroquine and chloroquine/sulfadoxine/pyrimethamine for treatment of acute Plasmodium falciparum malaria in The Philippines. J Infect Dis: (in press).
19. Blanchard TJ, Mabey DC, Hunt-Cooke A, Edwards G, Hutchinson DB, Benjamin S, Chiodini PL, 1994. Multiresistant falciparum malaria cured using atovaquone and proguanil. Trans R Soc Trop Med Hyg 88: 693.
20. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ, 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54: 62-66.
21. de Alencar FE, Cerutti C Jr, Durlacher RR, Boulos M, Alves FP, Milhous W, Pang LW, 1997. Atovaquone and proguanil for the treatment of malaria in Brazil. J Infect Dis 175: 1544-1547.
22. Mulenga M, Canfield CJ, Hutchinson DBA, 1999. Atovaquone/ proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia. Clin Ther: (in press).
23. Fry M, Pudney M, 1992. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol 43: 1545-1553.
24. Dollery C, 1991. Proguanil (hydrochloride). Ther Drugs 2: 247-251.
25. Canfield CJ, Pudney M, Gutteridge WE, 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 80: 373-381.
26. Rolan PE, Mercer AJ, Weatherly BC, Holdich T, Meire H, Peck RW, Ridout G, Posner J, 1994. Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 37: 13-20.
27. World Health Organization, 1973. Advances in malaria chemotherapy. World Health Organ Tech Rep Ser 529: 30-32.
28. Smith PG, Morrow RH, eds, 1991. Methods for Field Trials of Interventions Against Tropical Diseases. Oxford: Oxford University Press, 283.
29. Krogstad DJ, 1995. Plasmodium species (malaria). Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Fourth edition. New York: Churchill Livingstone, 2415-2427.
30. Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P, 1992. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988 II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg 46: 8-14.
31. Reacher M, Campbell CC, Freeman J, Doberstyn EB, Brandling-Bennett AD, 1981. Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980. Lancet 2: 1066-1069.
32. Looareesuwan S, Chulay JD, Canfield CJ, and Hutchinson DBA for the Malarone Clinical Trials Study Group, 1999. Malarone™ (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Am J Trop Med Hyg 60: 533-541.
33. Jiang JB, Li GQ, Guo XB, Kong YC, Arnold K, 1982. Anti-malarial activity of mefloquine and qinghaosu. Lancet 2: 285-288.
34. Li GQ, Arnold K, Guo XB, Jian HX, Fu LC, 1984. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet 2: 1360-1361.
35. Hudson AT, Dickins M, Ginger CD, Gutteridge WE, Holdich T, Hutchinson DB, Pudney M, Randall AW, Latter VS, 1991. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res 17: 427-435.
36. Watkins WM, Sixsmith DG, Chulay JD, 1984. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Ann Trop Med Parasitol 78: 273-278.
37. Peto TE, Newbold CI, Pasvol G, 1985. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria. Lancet 1: 216.
38. Wattanagoon Y, Taylor RB, Moody RR, Ochekpe NA, Looareesuwan S, White NJ, 1987. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol 24: 775-780.
39. Pudney M, Gutteridge W. Zeman A, Dickins M. Woolley JL, 1999. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. J Travel Med: (in press).
40. Shanks GD, Wilairatanaporn C, 1992. Eosinophilic response to falciparum malaria infections. Southeast Asian J Trop Med Public Health 23: 795-797.